Population Council

• 1. Introduction

  ›

  The Population Council was founded on an unusual premise: that the world's most pressing health problems could only be solved with rigorous science and a willingness to go where the need was greatest. John D. Rockefeller III gathered distinguished scientists in Williamsburg, Virginia, under the auspices of the National Academy of Sciences, to search for a better understanding of demographic trends. Shortly thereafter, in 1952, he established the Population Council as an independent, nonprofit organization in New York City. He served as its first president. What followed was a decades-long effort that would place contraceptives in the hands of tens of millions of people, document the spread of HIV across Africa before almost anyone else was paying attention, and shape the contours of global public health. The questions this organization forced the world to grapple with still define how governments and researchers think about poverty, reproduction, and disease today.

• 2. Rockefeller's Vision

  ›

  John D. Rockefeller III built the Council with important funding from the Rockefeller Brothers Fund and set up an international board of trustees to govern it. He served not just as founder but as a hands-on president before eventually stepping back to become non-executive chairman of the board. He held that role until his death in an auto accident in 1978. The line of presidents who followed him spans decades of evolving global priorities: Frederick Osborn served from 1957 to 1959, followed by Frank Notestein from 1959 to 1968, Bernard Berelson from 1968 to 1974, and George Zeidenstein from 1977 to 1992. Margaret Catley-Carlson took the role from 1993 to 1999, Linda Martin from 2000 to 2004, and Peter J. Donaldson from 2005 to 2015. Julia Bunting led through 2023, followed by interim co-Presidents Patricia C. Vaughan and James Sailer. On the 15th of May 2025, Vaughan and Sailer were appointed co-Presidents. Each president inherited an organization whose core mandate remained remarkably stable even as the specific challenges shifted around it.

• 3. Contraceptives That Changed Millions

  ›

  In the 1960s, the Council played a central role in documenting the large numbers of people in poor countries who lacked access to contraceptives. That documentation drove its researchers to act. The Council's biomedical scientists worked to develop the intrauterine device, and the organization was directly involved in bringing IUDs to India. The Copper T intrauterine device that resulted from this work has been distributed to more than 50 million people in over 70 countries. The Council held the license for Norplant, the contraceptive implant, which was later replaced by Jadelle, a two-rod implant that provides contraception for five years. The Council now holds the license for the Mirena intrauterine system. In 2018, the US FDA approved Annovera, a one-year contraceptive vaginal system the Council developed. The British medical journal Lancet observed that the Population Council had hard evidence of having changed the lives and expectations of hundreds of millions of people. The Council's collaboration with industry partner ProMed Pharma to develop vaginal rings aimed at making STI prevention more acceptable and effective for women shows that this work is far from finished.

• 4. HIV on the Front Lines

  ›

  One-third of the Council's research relates to HIV and AIDS, a proportion that reflects just how central the epidemic became to the organization's work. The Population Council was one of the first organizations to document statistics on HIV in Africa, and it conducted the first study in India to assess the HIV risks facing injecting drug users. These were not small achievements at the time. A project called Empowering Girls and Young Women at High Risk of HIV Infection operates across 15 African countries, reaching the populations with the highest risk of transmission and connecting them with preventive resources. The Council also partners in a project called Link Up, based in Bangladesh, Burundi, Ethiopia, Myanmar, and Uganda, which focuses on young people ages 10 to 24. That age group represents a substantial share of HIV infections in those regions. The Council's research helped implement more effective strategies for improving sexual and reproductive health outcomes for those populations.

• 5. Gender, Violence, and Youth

  ›

  The Council's work on gender sits alongside its biomedical programs as a distinct and substantial commitment. Programs like Opening Opportunities are designed to build the social networks of girls most at risk of sexual or gender-based violence, connecting them with mentors who help them stay safe. The Council also strives to teach boys that they can be involved in contraceptive methods regardless of stereotypes that limit male responsibility in childbearing. This reflects a broader conviction that reproductive health decisions are shaped by social norms, not just by access to products. The Council conducts social science research to understand the factors influencing access to contraceptives and the decision-making that surrounds them. Its finding that fertility is most sensitive to changes in the proportions married and prevalence of contraception points to why cultural attitudes, not just supply chains, determine outcomes. A country's ideas around reproduction out of wedlock, and the public's opinion of birth control, are, by the Council's own assessment, instrumental in determining fertility in that region.

• 6. A Global Research Presence

  ›

  Headquartered in New York City, the Population Council operates 18 offices across Africa, Asia, and Latin America and does work in more than 60 countries. It employs nearly 400 people from 33 countries, with roughly 55 percent based outside the United States. The annual budget runs around $74 million. The Council publishes two journals that serve as channels for this research: Population and Development Review reports on the interrelationships between population and socioeconomic development, and Studies in Family Planning covers public health, social science, and biomedical research involving sexual and reproductive health, fertility, and family planning. As of the 2006 board composition, the Council drew its governance from leaders across biomedicine, business, economic development, government, health, international finance, media studies, philanthropy, and social science. That breadth of oversight reflects an organization that has always understood the problem it is solving as too large for any single discipline to contain. The Annovera approval in 2018 remains one of the most recent markers of what sustained, science-driven work at scale can produce.